Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 11682  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal


Year : 2021  |  Volume : 69  |  Issue : 6  |  Page : 1729--1736

Assessing Utility of Clinical Exome Sequencing in Diagnosis of Rare Idiopathic Neurodevelopmental Disorders in Indian Population

1 RIGE's Institute of Human Genetics, FRIGE House, Jodhpur Gam Road, Satellite, Ahmedabad, Gujarat, India
2 Strand Life Sciences Private Limited, Bengaluru, Karnataka, India
3 Mayflower Woman's Hospital, Ahmedabad, Gujarat, India
4 Sheth V. S. General Hospital and NHL Municipal Medical College, Ahmedabad, Gujarat, India
5 Sir Takhtasinhji General Hospital, Bhavnagar, Gujarat, India

Correspondence Address:
Dr. Harsh Sheth
FRIGE's Institute of Human Genetics, FRIGE House, Satellite, Ahmedabad - 380 015. Gujarat
Jayesh Sheth
FRIGE's Institute of Human Genetics, FRIGE House, Satellite, Ahmedabad - 380 015. Gujarat
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.333475

Rights and Permissions

Background: Neurological diseases are phenotypically and genotypically heterogeneous. Clinical exome sequencing (CES) has been shown to provide a high diagnostic yield for these disorders in the European population but remains to be demonstrated for the Indian population. Objective: The study aimed to understand the utility of clinical exome sequencing for the diagnosis of neurodevelopmental disorders. Materials and Methods: A cohort of 19 idiopathic patients with neurological phenotypes, primarily intellectual disability and developmental delay, were recruited. CES covering 4620 genes was performed on all patients. Candidate variants were validated by Sanger sequencing. Results: CES in 19 patients provided identified 21 variants across 16 genes which have been associated with different neurological disorders. Fifteen variants were reported previously and 6 variants were novel to our study. Eleven patients were diagnosed with autosomal dominant de novo variants, 7 with autosomal recessive and 1 with X-linked recessive variants. CES provided definitive diagnosis to 10 patients; hence, the diagnostic yield was 53%. Conclusion: Our study suggests that the diagnostic yield of CES in the Indian population is comparable to that reported in the European population. CES together with deep phenotyping could be a cost-effective way of diagnosing rare neurological disorders in the Indian population.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow